Keywords: janssen, files, first, dossier, galantamine, janssen-cilag, filed
Janssen files first dossier for galantamine
Article | 08 April 1999
Janssen-Cilag has filed for European approval of Reminyl (galantamine)for the treatment of mild-to moderately-severe Alzheimer's disease. The drug has ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
